CRM

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

+0.58%

Status

scored

Maintaining Hold on CRM at $227.80 with a $212 hard closing-basis stop that sits below the 50 SMA ($223.80) but above the 200 SMA ($199.08), calibrated for the $8.44-8.78 ATR regime to avoid the whipsaw issues that plagued the 10/5 and 10/2 Holds. The $212 stop honors the 10/7 binding reflection lesson that "the $212 closing-basis stop should have been the trade, not the trim," respecting the 200 SMA floor while providing clear technical downside if the Tier-1 floor thesis breaks. Upgrade triggers include close above $232 with MACD/RSI confirmation or Agentforce ARR disclosure >$500M at Q3 FY27 earnings; downgrade triggers include close below $212 on volume >8M shares or Q3 EPS miss with negative guide.

Outcome

✗

Return

+1.44%

Status

scored

Trim 20-30% of CRM position at $224 with a closing-basis stop at $212; the Underweight rating reflects two consecutive Hold losses (-2.6% and -2.8% alpha) that mandate a directional posture per the binding 10/5 reflection. Technical breakdown (MACD -2.91, lost 10 EMA, lower highs since 9/3) and hostile macro (10Y at 2002 highs, 96% no-cut odds through 2026) justify the trim, but the Tier-1 floor ($17.7B FCF, 200 SMA at $199.23, 77% gross margins) prevents a full Sell.

Outcome

–

Return

-0.19%

Status

scored

Salesforce receives an Underweight rating based on the 10/5 binding reflection mandating directional posture after two consecutive Hold calls (-2.8% and -2.6% alpha) both underperformed the rejected Underweight alternative (-0.7%). The tranche execution framework calls for reducing exposure to 50-70% of benchmark weight via a 10% trim at current $224-225 levels plus an additional 10-15% trim on any rally into the $230-232 resistance zone, balancing bear-case convexity against the Tier-1 structural floor support at the 50 SMA ($222.14) and 200 SMA ($199.86).

Outcome

✓

Return

-2.09%

Status

scored

Maintain CRM position at $229.79 with Hold rating based on three converging factors: the Aggressive Analyst wins on valuation (14.3x P/E, 9.4% FCF yield, 21%+ operating margins) but loses on timing with overstated 3.8:1 risk/reward vs. actual 1.3:1, the Conservative Analyst is right on leverage risks ($2.40/share structural drag, zero Agentforce disclosure) but wrong on magnitude given Tier-1 floor intact, and the Neutral Analyst's synthesis correctly weights Agentforce as "yellow flag" rather than fabricated narrative. Execution framework is simplified per historical lessons: stop at $215, add trigger at $220-225, trim at $240-245 on volume >12M, with mandatory reassessment at Q3 FY27 earnings (~7-8 weeks).

Outcome

✓

Return

-2.09%

Status

scored

Maintain CRM exposure at current weight with no new capital deployment at current price ($234.69), which sits literally on the 10-EMA as a neutral coin-flip level. Initiate 15-25% trim at $255-260 resistance and a 10-15% trim on confirmed close below $234.65 on above-average volume; hard stop at $219-221 structural confluence—not the trader's $199, which represents a 15.2% drawdown absorbing 1.7 ATR adverse move. Re-enter only at $199-200 (200 SMA) on momentum reset confirmation (MACD histogram turning less negative, RSI >40). Mandatory reassessment at Q3 FY27 earnings in approximately 8 weeks.

Outcome

✗

Return

-0.84%

Status

scored

Overweight rating on CRM with 3-4% portfolio weight via staged execution ($50% at $236-240, 25% at $225-230, 25% at $242 with volume confirmation). Single hard stop at $215 with trim trigger at $260-265 to lock 10-12% upside ahead of macro ceiling. Setup improved enough (MACD histogram contracted 25% in two sessions, RSI held neutral through 14% pullback, 50 SMA at $218 defended) to warrant graduated exposure, but unresolved Q3 binary catalyst and macro headwinds prevent full Buy conviction.

Outcome

✗

Return

+3.10%

Status

scored

The consensus Hold rating reflects convergence among Research Manager, Trader, Conservative, and Neutral analysts, with only Aggressive dissenting. Execution favors simplicity: a single hard stop at $199.86 (200 SMA), one 10% trim into rallies toward $240-250, and two re-entry triggers—a defended 50 SMA test at $216.73 with MACD divergence or a volume-backed 10 EMA reclaim at $234—keyed to Dreamforce and Q3 FY27 earnings reassessments.

Outcome

✓

Return

+1.89%

Status

scored

The portfolio manager recommends HOLD on CRM, maintaining current exposure rather than trimming given the Tier-1 floor fundamentals (14x forward P/E, 0.76 PEG, 40% FCF margin, $17.7B FCF) and the empirical record showing prior Underweight calls on this exact template produced only modest alpha (+1.0% to -2.1%). The decision overrides the mechanical Underweight default with execution refinements including widened ATR-adjusted stops ($188-190), loosened add triggers ($200-215), and a binding mandatory reassessment at Q3 FY27 earnings (late November).

Outcome

✓

Return

-0.86%

Status

scored

The analyst shifts to Underweight from prior Hold calls, recommending a 45-55% trim of CRM overweight exposure via a three-tiered execution strategy ($1/3 at $228-232, $1/3 at $222-226, $1/3 at $214-218) with total portfolio cap at 1.5%. A hard thesis-invalidation stop is set at $213 (below 50 SMA at $214.50), with reload triggers at the $200-205 capitulation zone or a confirmed $264 retest on Agentforce ARR disclosure exceeding $2B, and mandatory reassessment at Q3 FY27 earnings in late November.

Outcome

✓

Return

-2.88%

Status

scored

Override the risk-analyst consensus Hold to apply Underweight-with-defined-re-entry per the binding 9/24 reflection, which triggers on every condition of the failure-mode template. Trim 40-50% of CRM exposure via tiered execution (1/3 at $230-233, 1/3 at $225-228, 1/3 at $215-220) and anchor a hard stop at $199 (200 SMA structural reference), preserving 50-60% residual exposure to honor the Tier-1 floor ($17.7B FCF, 34.8B backlog, 98% recurring revenue).

Outcome

✓

Return

-1.76%

Status

scored

Maintain CRM at ≤5% portfolio weight with a binding $195 hard stop on daily close as thesis-invalidation discipline, combining the Tier-1 floor thesis (14.9x forward P/E, 35% FCF margin, $14.2B capital return, $1.5B Agentforce ARR) with confirmed technical deterioration (below 10 EMA $242.27, 20 SMA $247.30, VWMA $248.08; fresh MACD bearish cross) and hostile macro (10Y at 2007 highs, 97% no-cuts probability). A probabilistic 50 SMA trim rule and 15-20 session time-decay trigger provide execution discipline, with an expanded $215-220 half-position add zone if technical confirmation occurs.

Outcome

✓

Return

+0.27%

Status

scored

Maintain CRM at 5% max portfolio weight with a binding $200 hard stop. The Hold reflects that while the franchise floor ($17.7B FCF, 34.8B backlog, 98% recurring revenue) justifies core exposure, the buyback tailwind is already harvested (forward pace $5-8B not $25B), the aggressive analyst's options-skew asymmetry thesis is mathematically wrong (symmetric dispersion, not directional edge), and the 0.5x to 2.4x leverage transformation is structural risk. Three prior passive Holds produced documented alpha bleed (-1.3%, -2.2%, -1.6%), mandating explicit 15-20 session time-decay reassessment triggers rather than indefinite holding into the Q3 FY27 earnings catalyst.

Outcome

✗

Return

+1.84%

Status

scored

Trim 40-50% of CRM exposure via tiered execution ($1/3 at $230-233, $1/3 at $225-228, $1/3 at $215-220) with a $199 hard stop and a simple $230/$200 put spread hedge sized at ~1% of remaining position to navigate the Oct 29 Fed meeting and Q3 FY27 earnings catalysts. Reassess at Q3 FY27 earnings with conditional re-entry triggers at $200-205 (capitulation) or $264 (confirmed retest with Agentforce ARR disclosure >$1B).

Outcome

✓

Return

-1.33%

Status

scored

Maintain CRM at current exposure with a $200 hard stop on daily close (200 SMA structural reference) and no incremental adds or trims at the current $236 price. Tactical position adds are only permitted on three specific triggers: pullback-hold at $200-208 with declining volume and bullish reversal candle, volume-expanding reclaim of $250-252 with MACD repair, or constructive Q3 FY27 earnings confirmation in late November. Consider partial hedging via $190-200 puts (60-90 day) at approximately 1% of position cost as tail-risk insurance, with mandatory time-decay reassessment if no basing pattern confirms within 15-20 sessions.

Outcome

✓

Return

-0.63%

Status

scored

Maintain CRM at current exposure with a $198 hard stop on daily close (just below the 200 SMA at $200.61), permitting tactical adds only on a confirmed 200 SMA hold with bullish reversal candle and RSI re-anchor to 45-55. Consider partial hedging via $190-$200 puts (60-90 day, ~1% of position cost) as asymmetric tail-risk insurance through the Q4 FY27 earnings catalyst (late Feb/early March 2027).

Outcome

✓

Return

-2.03%

Status

scored

Underweight rating reflects unanimous bearish consensus across all analyst archetypes, with trim to 60-70% of benchmark weight via tiered limit orders (1/3 at $252-255, 1/3 at $258-262, 1/3 at $264-268) to capture gains from the 65% three-month rally. The binding mechanical collar (sell $275 calls / buy $235 puts, 3-6 month) must be entered before the Q3 FY27 catalyst, sized to absorb the expected move—not layered as a residual hedge—with a $200 daily close hard stop at the 50/200 SMA confluence.

Outcome

✓

Return

-3.07%

Status

scored

Maintain Underweight on Salesforce (CRM) with a 30-35% trim at $250.54 to lock in gains from the 65% three-month rally, while retaining 65-70% residual exposure to honor the Tier-1 compounder floor ($17.7B FCF, A/A2 rating). Tighten the stop to $243 (twice-tested pivot low) and implement the Research Manager's mechanical collar (selling $275 calls/buying $235 puts, 3-6 month) as the primary bearish expression mechanism rather than trim magnitude alone, per the binding 9/14 reflection. Defined re-entry triggers at $215-220 (first scale) and $195-205 (second scale) replace calendar-based embargoes, with Q3 FY27 earnings (late November) as the binary catalyst window for tactical reassessment.

Outcome

✓

Return

-2.00%

Status

scored

Maintain CRM at 3-4% portfolio weight with a HOLD rating as Dreamforce approaches in 48 hours, using a calibrated two-tier stop architecture ($243 tactical alert, $215 hard stop, $201 structural reference) and optional $250 December puts hedge at ~1% of position cost to balance intact fundamentals against technical deterioration and macro headwinds.

Outcome

✓

Return

-1.46%

Status

scored

Trim 20-25% of CRM exposure at $258-262 to honor the unanimous bearish consensus while maintaining ~75-80% core position to preserve asymmetric participation in $17.7B FCF, $22B deferred revenue, and Agentforce $1.5B ARR (+240% YoY). Set hard stop at $278, maintain December $250 puts at ~1% of position cost, and deploy trimmed proceeds as dry powder for tactical re-engagement at $248-252 only if Dreamforce disappoints with structural confirmation.

Outcome

✓

Return

+4.73%

Status

scored

Maintain CRM exposure with a 10-15% trim at current levels ($245-250) ahead of Dreamforce/FOMC, preserving ~85% position. Hard stop at $228 with 10 EMA at $245.50 as event-window trailing reference; reload plan armed at $210-215 zone on 1/3 tranche basis.

Outcome

✗

Return

+1.94%

Status

scored

The binding call is Underweight with a 20-25% trim of the CRM position into the $240-245 strength zone via tiered limit orders, retaining 75-80% core exposure. The technical deterioration is severe (first MACD signal-line cross below zero since the rally began, RSI 82→62.6 in one week, three consecutive lower closes after a 76% vertical move), and while the fundamental thesis remains intact ($17B FCF, Agentforce $1.5B ARR at +240% YoY), the combination of hostile macro backdrop into Dreamforce and expensive 30x normalized P/E warrants reducing exposure rather than full exit or passive hold. Reload triggers are set at $215-220 for Tier 1 and above $260 with volume >30M for Tier 2.

Outcome

✓

Return

-0.48%

Status

scored

Maintain an 80-85% core CRM position while executing a 15-20% trim at $244-248 to honor a binding MACD reflection (73% histogram collapse in 3 sessions) ahead of the Dreamforce catalyst in 9 trading days; use trimmed proceeds as dry powder for defined reload triggers or optional Dreamforce call spreads. Stop levels are set at $230 (mental noise stop) and $215 (hard structural invalidation), with $240-245 December puts recommended as a tail-risk collar at 1-1.5% of position cost.

Outcome

✓

Return

-1.99%

Status

scored

Maintain CRM at approximately 85% of current position with a 10-15% trim executed at current levels ($248-251) and a tightened trailing stop architecture anchored at $240.19 VWMA. The structural bull thesis (Agentforce, $14.4B FCF, 21.5% operating margins) remains intact, but the extension-plus-divergence setup requires trimming existing exposure rather than passive hold. Deploy trimmed proceeds as dry powder for defined reload zones ($230-240 pullback, $205-215 gap-fill) with $250 December puts as tail-risk hedge.

Outcome

✓

Return

-3.90%

Status

scored

Maintain CRM at current weight without adding at the $259 reference price ahead of next week's FOMC and CPI binary events; preserve exposure to the structural bull case (Agentforce $1.5B ARR at +240% YoY, $17.7B TTM FCF) while capping tail risk via $250 December puts at ~1% of position cost. Defer fresh capital deployment until either a confirmed pullback to $230-244 with RSI cooling to 55-60 materializes post-macro resolution, or a breakout above $277 on volume >40M shares confirms momentum.

Outcome

✓

Return

-1.97%

Status

scored

Maintain CRM at model weight with no trim. The binding 9/2 reflection establishes Hold-with-hedge as the default for this archetype. Deploy $250 December puts at ~1% of position cost as a tail-risk collar.

Outcome

✓

Return

+2.92%

Status

scored

Maintain CRM at model weight with a Hold-with-hedge structure rather than executing the trader's SELL or research manager's Underweight trim. Deploy $250 December puts at ~1% of position cost as a tail-risk collar against the three-month catalyst window; the prior 8/26 and 9/1 lessons with structurally identical bearish signals (RSI 80, debt +276%, manufactured EPS) produced alpha losses on Underweights and +1.8% alpha on the 8/28 Hold, making the Hold-with-hedge the highest-expected-value path.

Outcome

✓

Return

-0.46%

Status

scored

Reduce CRM to 55-65% benchmark weight via a 25-35% trim into $255-260 to capture gains from the 40% rally while preserving core exposure to the AI re-rating thesis; set hard stop at $232 close (~2.5 ATR from entry) with no fresh initiation at current levels—instead wait for pullback to $232-240 with RSI cooling to 50-60 and declining volume before re-engaging.

Outcome

✓

Return

+0.22%

Status

scored

Maintain Overweight rating with staged 2-2.5% portfolio weight entry, prioritizing the $230-245 pullback zone (40-50% of allocation) while using smaller starter tranches if RSI cools or breakout above $258 confirms. Hedge Q3 FY27 binary risk via $235 December puts at 1% of position cost, with contextual stops at $218 (pullback fills) or $245 (above-$258 fills). Price targets range from T1 $275 to T3 $315-330, with full thesis reassessment at 12 months post-Q3 FY27 results.

Outcome

✓

Return

+0.60%

Status

scored

Maintain existing CRM exposure at model weight with no additions at current levels ($256) due to extended technical conditions (RSI 80.8, +16.5% above 10 EMA) and immediate overhead resistance at the December 2025 peak ($256–$269). For new capital, wait for pullback confirmation to the $215–$225 zone (10 EMA / gap fill) offering 2:1 to 3:1 risk/reward, with hard invalidation below $215 on heavy volume requiring exit of all exposure.

Outcome

✗

Return

+1.57%

Status

scored

Maintain an Underweight rating on CRM with a recommendation to trim 25-35% of the position at $250-252 (using limit orders), capturing gains from the +22.6% single-day move while preserving core exposure to a potential multi-quarter trend reversal; hard stop set at $228 close (approximately 9.5% below current levels). Do NOT initiate new positions at current levels; instead wait for either an orderly pullback to the $228-235 zone with RSI 55-65 and declining volume, or a confirmed breakout above $269 on volume. Position sizing capped at 1.5% of risk capital until RSI resets below 60 with 3-5 sessions of consolidation, per the post-Jackson Hole reaction function.

Outcome

✗

Return

+22.58%

Status

scored

Trim CRM to 55% benchmark weight at current levels ($205-210) rather than chasing further upside into known resistance. Deploy $185-strike put options (45-60 DTE) immediately to hedge, with a stop at $212 close and two-tranche reload targets at $185 and $178; hard floor at $173, capped at 1.5% of risk capital. The bear case centers on buyback-driven EPS (70% of beat from $30B debt issuance), late-stage technical exhaustion at resistance with compressing MACD, and asymmetric risk-reward (~4-5 pts upside vs ~9 pts downside).

Outcome

✓

Return

-0.03%

Status

scored

Maintain CRM at model weight with immediate hedge deployment (either $185-strike puts at 45-60 DTE or a collar structure) rather than trimming or adding ahead of the August 26 Q2 FY27 print. Hard stop $194 on closing basis to avoid binary gaps; cap position at 1.5% of risk capital until the 200-SMA turns up in 4-6 weeks.

Outcome

✓

Return

-1.61%

Status

scored

CRM warrants an Underweight rating given confirmed failed reacceleration (sequential revenue -0.6% Q4→Q1), consensus Q2 deceleration to 10.6%, and materially degraded balance sheet (D/E 29%→124%), but the trim should be calibrated to 25-35% rather than the trader's conviction-level 50% to avoid repeating the 8/17 mistake that bled +3.4% alpha — execute immediately at $207-210 into strength with $185-strike put hedge (45-60 DTE) and hard stop at $228, with half-normal conviction on the residual position until the Q2 FY27 print resolves the binary catalyst.

Outcome

–

Return

-0.05%

Status

scored

Maintain a measured CRM long via a three-stage plan: Stage 1 at 0.3-0.5% of risk capital at $209-210, Stage 2 contingent on a confirmed pullback to $192-198 with RSI reset, and Stage 3 on post-earnings beat-and-raise. Cap total position at 1.5% risk capital with hard stop at $189 (2.6x ATR); trim reference at $220-225. Rating upgraded from neutral to Overweight given 200 SMA reclaim, cheap valuation (13.5x forward P/E, 9.7% FCF yield), and Agentforce momentum, but full deployment deferred until stacked binaries (earnings, Jackson Hole, NVDA) resolve.

Outcome

✓

Return

+1.82%

Status

scored

Maintain CRM at neutral weight (2-3% software/tech allocation) with immediate deployment of $185-strike put hedges (45-60 DTE, 2-3% of position cost) rather than adding at $205 or holding net-short; cap position at ≤3% until 8/26 earnings resolves binary catalyst, with hard stop at $188 (close below) and trim reference at $220-225.

Outcome

✓

Return

-0.32%

Status

scored

Maintain HOLD rating at $206 as expected value is roughly balanced with modest negative tilt from binary asymmetry. Deploy the $185-strike put hedge (45-60 DTE, ~2-3% of position cost) immediately rather than holding in reserve per the 8/13 reflection. Hard stop is $173 (50-DMA) on sustained close below, with tiered add zones at $200-203 (200-DMA stabilization), $195-200 (holding 10-EMA), and $187-195 (RSI<40 with reversal candle).

Outcome

✗

Return

+5.07%

Status

scored

Trim 20-25% of CRM position while deploying a $185 put hedge (45-60 DTE, ~2-3% of position cost) rather than executing a conviction trim, per the binding 8/17 lesson against proactive cuts when MACD is flattening-but-positive. Widen the hard stop to $185 and hold ~3% portfolio weight (60% of benchmark), with re-engagement triggers at $210 on high volume post-8/26 print.

Outcome

✗

Return

+2.71%

Status

scored

Trim CRM to ~60-65% of benchmark weight (40% reduction) before the 8/26 earnings print, using limit orders in the $192-$196 zone. Maintain a hard stop at $205 daily close. Rebuild to neutral (~85% benchmark) only on confirmed close above $210 with volume exceeding 10M shares; otherwise remain underweight given asymmetric downside risk from FCF guidance binary and bearish technical re-assertion.

Outcome

✓

Return

-2.67%

Status

scored

Maintain CRM exposure at ≤60% of normal weight with the $185 put hedge deployed immediately (1-2 month expiry, ~2-3% of position cost), pending Q2 FY27 earnings as the binary catalyst; the prior Hold's -2.4% alpha loss is attributed to delayed hedge deployment, so execution timing is the binding refinement distinguishing this from prior Holds.

Outcome

✓

Return

-2.56%

Status

scored

Maintain CRM at neutral weight given a balanced risk/reward setup with the August 26 Q1 FY27 earnings as the defining binary catalyst. The 12.97x forward P/E and 38.6% FCF margins support valuation, but 12 consecutive months of 200 SMA rejection, an intact death cross, and a capital structure regime change argue against fresh initiation until the catalyst resolves.

Outcome

✗

Return

+4.16%

Status

scored

Reduce CRM exposure by 25-30% at current $193 level, tightening the stop to $182 on the remaining position. The recommendation reflects 12 consecutive months of 200 SMA rejection at $203, a death cross regime, heroic forward EPS consensus ($15.51 from $8.63 TTM), and an upcoming Q2 FY27 binary catalyst in 4-6 weeks. Re-engage on a pullback to $180-185 with constructive price action or a confirmed daily close above $207 on volume >20M shares.

Outcome

✗

Return

-2.10%

Status

scored

Initiate a staged Overweight position in CRM at entry $197.50 with 2.5–3.0% portfolio weight, deploying ~1.25–1.5% now and reserving ~1.25–1.5% for a confirmed daily close above $204 on volume >20M shares, with a hard stop at $172 on the full position and upside targets of $215, $225, and $235–245 on breakout extension. Q2 FY27 earnings is the binary catalyst that will resolve the leverage/reacceleration debate, with the staged structure designed to capture fundamentals while respecting technicals.

Outcome

–

Return

-0.02%

Status

scored

Execute a 40-50% trim on CRM into the $200.00-$203.00 resistance zone (200 SMA/Bollinger upper band rejection cluster), waiting for price to reach that zone rather than trimming at current $197 levels. Retain 50-60% of the position with a $204.50 daily close stop and a $171 structural stop, while re-engaging on any breakout above $204.50 confirmed by volume ≥1.5x the 30-day average. Full position reassessment scheduled at Q2 FY27 earnings given structural concerns including the D/E ratio explosion from 29% to 124% and negative working capital of -$5.9B.

Outcome

✓

Return

+2.47%

Status

scored

Maintain CRM at $192.74 under a HOLD rating pending Q2 FY27 earnings catalyst in 4-6 weeks, with tiered execution rules: defend the $176 hard stop, add 25-33% position sizing on pullback to $185-187 with constructive price action, upgrade to Overweight only on confirmed close above $203 (200 SMA) on volume ≥1.5x 30-day average, and downgrade to Underweight only on break below $176 on rising volume. The analyst consensus reflects genuinely balanced evidence with neither bull nor bear case commanding directional conviction, making HOLD the correct calibrated response rather than a soft buy or preemptive trim.

Outcome

✓

Return

+3.20%

Status

scored

Maintain CRM at neutral weight with a trim of 10-15% into the $196 upper Bollinger band rejection and a hard stop at $170 (50 SMA with ~2x ATR buffer), scaling in modestly at the $177-180 VWMA zone while avoiding new capital deployment above $187 until Q2 FY27 earnings resolves the binary catalyst; the HOLD reflects that while the fundamental case (12x forward P/E, $16.55B TTM FCF, $1.6B VA Agentforce contract) is compelling, the current entry timing, sector rotation, and macro stack create asymmetric optionality burn over the next 4-6 weeks.